Gundlach Andrew purchased $2.4M of WELL (indirect holdings)

Gundlach Andrew purchased 10,000 indirectly-held shares of WELLTOWER INC. (WELL) at an average of $240.76 ($239.47–$242.06, $2.41M total) across 4 trades over 2026-08-25 to 2026-08-26.

Original reporting
SEC EDGAR · Gundlach Andrew
Published Aug 27, 2026, 8:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 8:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WELL
Bullish
medium confidence
Mentioned
$WELL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WELLBullishMed
01

Why it matters

The director's purchase adds 30,000 shares to his holdings, indicating personal confidence but limited market effect.

02

Market read

Minor insider buying; may be noted by REIT analysts but unlikely to drive significant price movement.

03

What to watch

Potential upcoming REIT acquisitions or dividend policy changes not disclosed.

Relevance 7/10Novelty 6/10Timing: post‑filing today

Background

Form 4 filing discloses insider transactions; WELL is a large‑cap healthcare REIT.

Company-level read

Ticker impact

$WELLBullishMedium confidence
Context

Director Andrew Gundlach bought 10,000 WELL shares for $2.4M via open‑market purchases on 2026‑08‑25/26.

Expected impact

Potential slight upside pressure, unlikely to move price materially.

Evidence & confidence

Purchase size is small relative to market cap; director ownership increase modest.

Market effects

Limited; insider activity may be noted by healthcare REIT investors.

None

None

Counterpoint

Insider purchase could be a routine portfolio rebalancing, not a strong buy signal.

Key entities

  • Andrew Gundlach

    Director of WELLTOWER INC. who purchased shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WELLHighAI 8/10

Mizuho doubles down on top REIT pick as senior housing growth gains momentum

Mizuho reiterated Welltower (WELL) as its top REIT pick, citing strong senior housing demand, improving margins, and an expanding acquisition pipeline. Welltower's Q3 FFO beat estimates at $1.67 per share, up 25% YoY, leading to raised full-year guidance. Mizuho maintained an 'outperform' rating and $260 price target, highlighting growth potential despite economic challenges. Senior housing occupancy rose to over 90%, and the company is expanding in skilled nursing and the UK.

$WELLHigh

What Is Behind The Move In Welltower Stock?

Welltower (WELL) stock fell 5.8% on October 27, 2026, after reporting Q3 results. Net income was $0.54 per share, missing estimates, while revenue exceeded expectations at $3.72B. Normalized FFO per share rose 24.6% YoY to $1.67, beating estimates. The company raised its full-year outlook midpoint to $6.50 per share. Peers also declined, with Ventas falling 4.7%. WELL stock is up 29.3% over the past year.